Sana Biotechnology

SanaModel SC276 (CD22 (+CD19)) - T Cells - Hypoimmune Technology: Donor-derived

SHARE

Oncology;  Non-Hodgkin lymphoma (NHL), Acute lymphoblastic leukemia (ALL), Chronic lymphocytic leukemia (CLL).